PRG-N-01
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PRG-N-01, covering 2026-01-23 to 2026-01-23. Get the full timeline:
Most recent: Clinical Trial Update: Study to Determine Optimal Dose, Evaluate the Efficacy and Safety of PRG-N-01 in Patients With Neurofibromatosis Type II [Phase 1, Phase 2]